APA (7th ed.) Citation

SJ, B., CJ, H., CJ, D., SM, W., & E, M. (2009). Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. European journal of heart failure, 11(9), 887. https://doi.org/10.1093/eurjhf/hfp101

Chicago Style (17th ed.) Citation

SJ, Brunskill, Hyde CJ, Doree CJ, Watt SM, and Martin-Rendon E. "Route of Delivery and Baseline Left Ventricular Ejection Fraction, Key Factors of Bone-marrow-derived Cell Therapy for Ischaemic Heart Disease." European Journal of Heart Failure 11, no. 9 (2009): 887. https://doi.org/10.1093/eurjhf/hfp101.

MLA (9th ed.) Citation

SJ, Brunskill, et al. "Route of Delivery and Baseline Left Ventricular Ejection Fraction, Key Factors of Bone-marrow-derived Cell Therapy for Ischaemic Heart Disease." European Journal of Heart Failure, vol. 11, no. 9, 2009, p. 887, https://doi.org/10.1093/eurjhf/hfp101.